Earnings call Dr. Lal PathLabs reported Q1 FY26 revenue of ₹670 crore, up 11.3% YoY, with PAT growing 24.3% to ₹134 crore. EBITDA margin held strong at 28.7%. Management reaffirmed 11–12% full-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results